Metamark Genetics, Inc. Names Dr. Peter Maimonis As Senior Vice President And Chief Science Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics, Inc. ("Metamark" or the "Company"), a leader in commercializing high value urologic oncology products, announced today that Peter Maimonis, Ph.D., has joined Metamark's leadership team as Senior Vice President and Chief Science Officer, effective October 7, 2015.

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.